Interhemispheric EEG differences in olfactory bulbectomized rats with different cognitive abilities and brain beta-amyloid levels

Brain Research

Volumn 1232, Issue , 2008, Pages 185-194

  Bobkova, Natalia ^a   Vorobyov, Vasily ^a,b   Medvinskaya, Natalia ^a   Aleksandrova, Irina ^a   Nesterova, Inna ^a  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Frequency spectra; Learning; Morris test

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; COGNITION; CONTROLLED STUDY; DOT HYBRIDIZATION; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; HIPPOCAMPUS; INTERHEMISPHERIC TRANSFER; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; OCCIPITAL CORTEX; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; SHAM PROCEDURE;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; COGNITION; DATA INTERPRETATION, STATISTICAL; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; FUNCTIONAL LATERALITY; HIPPOCAMPUS; MALE; MAZE LEARNING; OLFACTORY BULB; RATS; RATS, WISTAR; SPACE PERCEPTION;

RATTUS;

EID: 50849108807     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.036     Document Type: Article

References (48)

1. Andreasen N., Sjogren M., and Blennow K. CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42. World J. Biol. Psychiatry 4 4 (2003) 147-155
2. Apostolova L.G., Steiner C.A., Akopyan G.G., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., and Thompson P.M. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch. Neurol. 64 10 (2007) 1489-1495
3. Bobkova N.V., Nesterova I.V., and Nesterov V.V. The state of cholinergic structures in forebrain of bulbectomized mice. Bull. Exp. Biol. Med. 131 5 (2001) 427-431
4. Bobkova N.V., Vorobjov V.V., Medvinskaya N.I., and Nesterova I.V. Electrophysiological markers of neurodegenerative process on model of sporadic form of Alzheimer's disease. Materials of the 2nd International Conference: "High Medical Technologies in XXI century", November 1-8, Spain, Benidorm (2003) 100
5. Davidson R.J. What does the prefrontal cortex "do" in affect: perspectives on frontal EEG asymmetry research. Biol. Psychol. 67 1-2 (2004) 219-233
6. Dringenberg H.C. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav. Brain. Res. 115 2 (2000) 235-249
7. Gal'chenko A.A., and Vorobyov V.V. Analysis of electroencephalograms using a modified amplitude-interval algorithm. Neurosci. Behav. Physiol. 29 (1999) 157-160
8. German D.C., Yazdani U., Speciale S.G., Pasbakhsh P., Games D., and Liang C.L. Cholinergic neuropathology in a mouse model of Alzheimer's disease. J. Comp. Neurol. 462 4 (2003) 371-381
9. Geula C. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology 51 1 Suppl 1 (1998) S18-S29
10. Glick S.D. Cerebral lateralisation in the rat and tentative extrapolation to man. In: Myslobotsky M. (Ed). Heimsyndromes: Physiology, Neurology, Psychiatry (1983), Academic Press, New York 7-26
11. Gray C.M., Engel A.K., König P., and Singer W. Synchronization of oscillatory neuronal responses in cat striate cortex: temporal properties. Visual neuroscience 8 4 (1992) 337-347
12. Hallam K.T., Horgan J.E., McGrath C., and Norman T.R. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat. Behav. Brain Res. 153 2 (2004) 481-486
13. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
14. Hozumi S., Nakagawasai O., Tan-No K., Niijima F., Yamadera F., Murata A., Arai Y., Yasuhara H., and Tadano T. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav. Brain Res. 138 1 (2003) 9-15
15. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., and Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. U S A. 101 1 (2004) 343-347
16. Kar S., Slowikowski S.P., Westaway D., and Mount H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci. 29 6 (2004) 427-441
17. Kavcic V., Fernandez R., Logan D., and Duffy C.J. Neurophysiological and perceptual correlates of navigational impairment in Alzheimer's disease. Brain 129 Pt 3 (2006) 736-746
18. Kikuchi M., Wada Y., Takeda T., Oe H., Hashimoto T., and Koshino Y. EEG harmonic responses to photic stimulation in normal aging and Alzheimer's disease: differences in interhemispheric coherence. Clin. Neurophysiol. 113 7 (2002) 1045-1051
19. Knott V., Engeland C., Mohr E., Mahoney C., and Ilivitsky V. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study. Neuropsychobiology 41 4 (2000) 210-220
20. Krieg W.J.S. Connections of the cerebral cortex. 1. The albino rat. A. Topography of the cortical areas. J. Comp. Neurol. 84 2 (1946) 221-275
21. Lakmache Y., Lassonde M., Gauthier S., Frigon J.Y., and Lepore F. Interhemispheric disconnection syndrome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 95 15 (1998) 9042-9046
22. Lehéricy S., Hirsch E.C., Cervera-Piérot P., Hersh L.B., Bakchine S., Piette F., Duyckaerts C., Hauw J.J., Javoy-Agid F., and Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330 1 (1993) 15-31
23. McKinney M., and Coyle J.T. Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions. J. Neurosci. 2 1 (1982) 97-105
24. Montplaisir J., Petit D., Gauthier S., Gaudreau H., and Decary A. Sleep disturbances and EEG slowing in Alzheimer's disease. Sleep Res. Online 1 4 (1998) 147-151
25. Morilak D.A., and Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int. J. Neuropsychopharmacol. 7 2 (2004) 193-218
26. Morris R.G.M. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
27. Nesterova I.V., Gurevich E.V., Nesterov V.I., Otmakhova N.A., and Bobkova N.V. Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 21 1 (1997) 127-140
28. Nesterova I.V., Bobkova N.V., Medvinskaya N.I., Samokhin A.N., and Aleksandrova I.Y. Morphofunctional state of neurons in the temporal cortex and hippocampus in relation to the level of spatial memory in rats after ablation of the olfactory bulbs. Neurosci. Behav. Physiol. 38 4 (2008) 349-353
29. Novoselova E.G., Bobkova N.V., Sinotova O.A., Ogai V.B., Glushkova O.V., Medvinskaya N.I., and Samokhin A.N. The immune state of bulbectomized mice. Dokl. Biol. Sci. 393 (2003) 505-507
30. Ostrovskaya R.U., Gruden M.A., Bobkova N.A., Sewell R.D., Gudasheva T.A., Samokhin A.N., Seredinin S.B., Noppe W., Sherstnev V.V., and Morozova-Roche L.A. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. J. Psychopharmacol. 21 6 (2007) 611-619
31. Otmakhova N.A., Gurevich E.V., Katkov Y.A., Nesterova I.V., and Bobkova N.V. Dissociation of multiple behavioral effects between olfactory bulbectomized C57Bl/6J and DBA/2J mice. Physiol. Behav. 52 3 (1992) 441-448
32. Podol'skii I.Y., Vorob'ev V.V., and Belova N.A. Long-term changes in hippocampus and neocortex EEG spectra in response to pharmacological treatments affecting the cholinergic system. Neurosci. Behav. Physiol. 31 6 (2001) 589-595
33. Pogarell O., Teipel S.J., Juckel G., Gootjes L., Moller T., Burger K., Leinsinger G., Moller H.J., Hegerl U., and Hampel H. EEG coherence reflects regional corpus callosum area in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 76 1 (2005) 109-111
34. Rizzo M., Anderson S.W., Dawson J., Myers R., and Ball K. Visual attention impairments in Alzheimer's disease. Neurology 54 10 (2000) 1954-1959
35. Robichaud M., Beauchemin V., Lavoie N., Dennis T., and Debonnel G. Effects of bilateral olfactory bulbectomy on N-methyl-d-aspartate receptor function: autoradiographic and behavioral studies in the rat. Synapse 42 2 (2001) 95-103
36. Roth T., Costa e Silva J.A., and Chase M.H. Sleep and cognitive (memory) function: research and clinical perspectives. Sleep Med. 2 5 (2001) 379-387
37. Sakurada T., Shima K., Tadano T., Sakurada S., and Kisara K. Sleep wakefulness rhythms in the olfactory bulb lesioned rat. Jpn. J. Pharmacol. 26 (1976) 605-610
38. Slotkin T.A., Cousins M.M., Tate C.A., and Seidler F.J. Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats. Neuropsychopharmacology 30 1 (2005) 52-57
39. Sokolovsky M. Muscarinic receptors in the central nervous system. Int. Rev. Neurobiol. 25 (1984) 139-183
40. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29 4-5 (2005) 627-647
41. Stevens A., Kircher T., Nickola M., Bartels M., Rosellen N., and Wormstall H. Dynamic regulation of EEG power and coherence is lost early and globally in probable DAT. Eur. Arch. Psychiatry Clin. Neurosci. 251 5 (2001) 199-204
42. Tadano T., Hozumi S., Yamadera F., Murata A., Niijima F., Tan-No K., Nakagawasai O., and Kisara K. Effects of NMDA receptor-related agonists on learning and memory impairment in olfactory bulbectomized mice. Methods Find. Exp. Clin. Pharmacol. 26 (2004) 93-97
43. Vorobyov V.V., and Ahmetova E.R. Muscarinic elucidation of EEG asymmetry in freely moving rats. Brain Res. 794 (1998) 299-303
44. Wada Y., Nanbu Y., Koshino Y., Yamaguchi N., and Hashimoto T. Reduced interhemispheric EEG coherence in Alzheimer disease: analysis during rest and photic stimulation. Alzheimer. Dis. Assoc. Disord. 12 3 (1998) 175-181
45. Wang J., Ikonen S., Gurevicius K., van Groen T., and Tanila H. Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res. 943 2 (2002) 181-190
46. Watanabe S., Fukuda T., and Ueko S. Changes in electroencephalogram of the rat following olfactory bulbectomy. Tohoku J. Exp. Med. 130 1 (1980) 41-48
47. Wrynn A.S., MacSweeney C.P., Franconi F., Lemaire L., Pouliquen D., Herlidou S., Leonard B.E., Gandon J., and de Certaines J.D. An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res. 879 1-2 (2000) 193-199
48. Yamamoto T., Jin J., and Watanabe S. Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav. Brain Res. 83 1-2 (1997) 57-62